The Drosophila gene bmm was flagged in a genome-wide transcriptome profiling experiment screening for nutritionally regulated and evolutionarily conserved lipolysis effectors. This gene is orthologous to members of the mammalian PNPLA (patatin-like phospholipase-domain-containing) or ATGL (adipose triglyceride lipase) family, several of which play roles in triglyceride hydrolysis, energy metabolism, and lipid droplet homoeostasis. For Dmel\bmm, classical loss-of-function alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated. There is an additional orthologous gene in flies, dob. The human gene PNPLA2 is implicated in a lipid-storage-related myopathy (MIM:609059).
A UAS construct of the wild-type human Hsap\PNPLA5 gene has been introduced into flies, but has not been characterized. None of the other human PNPLA genes has been introduced into flies.
Animals homozygous for loss-of-function mutations of bmm exhibit progressive obesity (measured as triacylglycerol content) during adulthood; they show incomplete storage-fat mobilization in response to starvation and resistance to starvation. Muscle function is also decreased, and fat accumulates in skeletal muscle. Chronic bmm overexpression depletes fat stores in a manner similar to that normally observed under conditions of food deprivation. Physical and genetic interactions for Dmel\bmm have been described; see below and in the gene report for bmm. Genetic interactions with Lsd-1 and Lsd-2 have been demonstrated; see FBhh0000497.
In Drosophila, lipolysis is under the control of multiple systems. In addition to the bmm-based pathway, a adipokinetic hormone signaling pathway regulates storage-fat accumulation and mobilization. Inactivation of components of the adipokinetic pathway also generates flies with excessive fat accumulation and limited fat-mobilization capability (see FBhh0000976). Phenotypes are additive: simultaneous loss of bmm and the adipokinetic receptor (AkhR) causes extreme obesity and blocks acute storage fat mobilization, even when food-deprived. Similarly, loss of both bmm and sphingolipid metabolism pathway member Sk2 (see FBhh0000977 for obesity phenotypes associated with defective sphingolipid metabolism) causes more muscle dysfunction than either mutant alone.
[updated Apr. 2020 by FlyBase; FBrf0222196]
Obesity is an abnormal accumulation of body fat, usually 20% or more over an individual's ideal body weight. Obesity is associated with increased risk of illness, disability, and death. (http://medical-dictionary.thefreedictionary.com/obesity).
The development of obesity is recognized as having both genetic and environmental components (https://www.sciencelearn.org.nz/resources/203-obesity-genetic-or-environmental).
PNPLA3 is associated with Non alcoholic fatty liver disease in multiple GWAS studies (see GWAS Catalog, below in 'External links').
Members of the PNPLA family play key roles in triglyceride hydrolysis, energy metabolism, and lipid droplet homoeostasis (discussed in Murugesan, et al., 2013; FBrf0221781).
Many to many (5 human to 2 Drosophila). Human genes are PNPLA1, PNPLA2, PNPLA3, PNPLA4 and PNPLA5.
Many to many (5 human to 2 Drosophila). Human genes are PNPLA1, PNPLA2, PNPLA3, PNPLA4 and PNPLA5.
High-scoring ortholog of human PNPLA2 and PNPLA3; moderate-scoring ortholog of PNPLA5 and PNPLA1 (2 Drosophila to 5 human). Dmel\bmm shares 52% identity and 70% similarity with human PNPLA2; it shares 32-36% identity and 51-57 similarity with PNPLA3, PNPLA5 and PNPLA1.